POPULATION PHARMACOKINETICS OF CEFPODOXIME IN BOTTLENOSE DOLPHINS (


Journal

Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians
ISSN: 1042-7260
Titre abrégé: J Zoo Wildl Med
Pays: United States
ID NLM: 8915208

Informations de publication

Date de publication:
Sep 2024
Historique:
accepted: 12 04 2024
medline: 10 9 2024
pubmed: 10 9 2024
entrez: 10 9 2024
Statut: ppublish

Résumé

Cefpodoxime proxetil is commonly used to treat cetacean patients with suspected or confirmed bacterial infections; however, pharmacokinetic data are needed to guide proper dosing in these species. Cefpodoxime proxetil is a time-dependent, semisynthetic, third-generation cephalosporin, appropriate for once-daily dosing and U.S. Food and Drug Administration-approved for use in dogs with a broad spectrum of activity including gram-positive and gram-negative species. The objective of this study was to evaluate the population pharmacokinetics of cefpodoxime in bottlenose dolphins (

Identifiants

pubmed: 39255202
doi: 10.1638/2023-0139
doi:

Substances chimiques

Anti-Bacterial Agents 0
Ceftizoxime C43C467DPE
Cefpodoxime 7R4F94TVGY

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

611-619

Références

Abdel-Rahman SM, Maxson S, Teo C, Hubbard AE, Kearns GL. Cerebrospinal fluid pharmacokinetics of cefpodoxime proxetil in piglets. J Clin Pharmacol. 2000;40(3):290–295.
Brown SA, Boucher JF, Hubbard VL, Prough MJ, Flook TF. The comparative plasma pharmacokinetics of intravenous cefpodoxime sodium and oral cefpodoxime proxetil in beagle dogs. J Vet Pharmacol Ther. 2007;30(4):320–326.
Carrillo NA, Giguère S, Gronwall RR, Brown MP, Merritt KA, O'Kelley JJ. Disposition of orally administered cefpodoxime proxetil in foals and adult horses and minimum inhibitory concentration of the drug against common bacterial pathogens of horses. Am J Vet Res. 2005;66(1):30–35.
Chow D, Stoskopf Michael K., Vedros N, Aucoin D. P. Ceftazidime pharmacokinetics after intramuscular administration in healthy bottlenose dolphin (
Clinical and Laboratory Standards Institute. CLSI report VET01: AST standards for bacteria isolated from animals. 5th ed; 2018. https://clsi.org/standards/products/veterinary-medicine/documents/vet01/
Clinical and Laboratory Standards Institute. CLSI report VET09: Understanding susceptibility test data as a component of antimicrobial stewardship in veterinary settings. 2nd ed.; 2024. https://clsi.org/standards/products/veterinary-medicine/documents/vet09/
Garcia Parraga D, Gilabert J, Valls M, Rodriguez J, Álvaro T, Rojo-Solis C, Encinas T. Updates on the pharmacokinetics of cefovecin (Convenia
Garcia Parraga D, Gilabert J, Valls M, Ros-Rodriguez J, Álvaro T, Rojo-Solis C, Encinas T. Pharmacokinetics of cefovecin (Convenia
Gulland FMD, Dierauf LA, Whitman KL (eds.). CRC handbook of marine mammal medicine. 3rd edition. Boca Raton (FL): CRC Press; 2018.
KuKanich B, Papich M, Huff D, Stoskopf M. Comparison of amikacin pharmacokinetics in a killer whale (
Linnehan RM, Ulrich RW, Ridgway SH. Enrofloxacin serum bioactivity in bottlenose dolphins,
McKellar QA, Sanchez Bruni SF, Jones DG. Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine. J Vet Pharmacol Ther. 2004;27(6):503–514.
Papich MG, Davis JL, Floerchinger AM. Pharmacokinetics, protein binding, and tissue distribution of orally administered cefpodoxime proxetil and cephalexin in dogs. Am J Vet Res. 2010;71(12):1484–1491.
Pfizer. Vantin tablets and oral suspension (cefpodoxime proxetil tablets and cefpodoxime proxetil oral suspension, USP). Package insert; 2013. https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/050674s015,050675s018lbl.pdf
Ross K, Le-Bert CR, Goe A, Meegan J, Johnson S, McClain A, Linnehan B, Lutmerding E, Gomez F, Smith CR, Ivancic M, Terio K, Colegrove K, Jensen E. Superficial cervical lymphadenitis associated with
Sader HS, Jones RN, Washington JA, Murray PR, Gerlach EH, Allen SD, Erwin ME.
Venn-Watson S, Daniels R, Smith C. Thirty year retrospective evaluation of pneumonia in a bottlenose dolphin
Venn-Watson S, Smith CR, Jensen ED. Primary bacterial pathogens in bottlenose dolphins
World Health Organization. WHO medically important antimicrobial list. 7th ed.; 2023. https://cdn.who.int/media/docs/default-source/antimicrobialresistance/amr-gcp-irc/who_mialist_draft_forexternaldiscussion.pdf?sfvrsn=af6f2ebf_1
Zoetis Inc. “Simplicef (cefpodoxime proxetil tablets)” package insert. https://www2.zoetisus.com/content/_assets/docs/vmips/package-inserts/simplicef.pdf

Auteurs

Barbara K Linnehan (BK)

National Marine Mammal Foundation, San Diego, CA 92106, USA, barb.linnehan@nmmf.org.

Steven P Lesman (SP)

Veterinary Medicine Research and Development, Zoetis Inc., Kalamazoo, MI 49007, USA.

Joseph F Boucher (JF)

Veterinary Medicine Research and Development, Zoetis Inc., Kalamazoo, MI 49007, USA.

G Scott Grover (GS)

Veterinary Medicine Research and Development, Zoetis Inc., Kalamazoo, MI 49007, USA.

Erin C Brodie (EC)

National Marine Mammal Foundation, San Diego, CA 92106, USA.

Jennifer M Meegan (JM)

National Marine Mammal Foundation, San Diego, CA 92106, USA.

Abby M McClain (AM)

National Marine Mammal Foundation, San Diego, CA 92106, USA.

Kyle P Ross (KP)

National Marine Mammal Foundation, San Diego, CA 92106, USA.

Eric D Jensen (ED)

U.S. Navy Marine Mammal Program, Naval Information Warfare Center Pacific, San Diego, CA 92106, USA.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH